Common heart attack drug useless for most patients, major study reveals

(NaturalHealth365)  For over 40 years, doctors have routinely prescribed beta-blockers to nearly every heart attack patient.  It’s been standard practice, written into international guidelines, and assumed to save lives.

Now, a new study published in The New England Journal of Medicine has upended this decades-old paradigm.  The REBOOT trial found that beta-blockers offer no clinical benefit for heart attack patients with preserved heart function – and a companion analysis in the European Heart Journal reveals something even more disturbing: Women taking beta-blockers faced significantly higher risks of death and cardiovascular events.

Study exposes shocking outcome of using beta-blockers

Researchers enrolled 8,505 patients across 109 hospitals in Spain and Italy.  All had experienced a heart attack and retained reasonably good heart-pumping ability (ejection fraction above 40%).  Half of the patients received beta-blocker therapy after discharge, while the other half received no beta-blockers.  All patients otherwise received the current standard care.

After 3.7 years, the results were clear: Beta-blockers made no difference in deaths, repeat heart attacks, or heart failure hospitalizations.

Women harmed more than men due to drug “therapy”

Among the 1,627 women in the study, those on beta-blockers had dramatically worse outcomes:

• 45% higher relative risk of death, reinfarction, or heart failure hospitalization
• 90% higher risk of all-cause death
• An excess absolute risk of 0.9% per year

Men showed no such increased risk.  The harm to women appeared most pronounced in those with preserved ejection fraction (≥50%) – the population with the best heart function – and those receiving higher doses.

New information demands that conventional cardiology change treatment options

Beta-blockers were added to heart attack treatment in the 1980s because they reduced mortality then.  But cardiac care has evolved dramatically.  Today, blocked arteries are reopened rapidly, drastically lowering complication risks.  Yet the beta-blocker recommendation persisted based on decades-old trials conducted before modern interventional cardiology became standard.

Why would beta-blockers harm women but not men?  Women achieve higher drug concentrations at the same dose due to lower body weight, higher body fat proportion, and reduced plasma volume.  They metabolize beta-blockers differently and experience greater cardiovascular effects.  Women also have smaller left ventricular cavity sizes, where beta-blockers may exert detrimental effects, particularly at higher doses.

The REBOOT trial was conducted without pharmaceutical industry funding – allowing researchers to ask uncomfortable questions about profitable, widely prescribed medications.

Natural solutions for heart health

Optimal cardiovascular health requires addressing root causes, not just pharmaceutical symptom management.

Whole food nutrition: Prioritize foods that naturally support heart function, such as wild-caught salmon and sardines for anti-inflammatory omega-3s, organic dark leafy greens rich in nitrates for blood vessel health, organic berries packed with heart-protective anthocyanins, and extra virgin olive oil for polyphenols that reduce oxidative stress.  Avoid the real culprits: trans fats, excessive fructose, and inflammatory vegetable oils that damage arterial walls.

Strategic nutrient support: Consider CoQ10 (especially vital for anyone on statins, which deplete this critical heart nutrient), L-carnitine for mitochondrial energy production in heart cells, taurine for electrical stability and blood pressure regulation, and nattokinase for supporting healthy blood flow.  Magnesium glycinate supports over 300 enzymatic reactions crucial for cardiovascular function.

Lifestyle factors that actually matter: Chronic stress elevates cortisol and damages blood vessels.  Practice heart rate variability training, prioritize restorative sleep (poor sleep independently doubles heart attack risk), and build meaningful social connections; isolation is as damaging to your heart as smoking.

Get the full picture to avoid heart problems

The beta-blocker revelation shows how conventional cardiology clings to outdated paradigms while ignoring root causes.  The pharmaceutical industry profits from lifelong medications, not from addressing inflammation, oxidative stress, insulin resistance, and nutrient deficiencies that actually drive cardiovascular disease.

Ready to discover what leading cardiovascular experts recommend for heart health?

Jonathan Landsman’s Cardiovascular Docu-Class brings together 22 top scientists, researchers, doctors, and nutritionists to reveal evidence-based approaches that mainstream cardiology ignores.  Discover functional lab tests that predict heart attacks years early, natural protocols for reversing arterial plaque, why standard cholesterol testing misleads, the gum disease-heart connection, and the truth about drug-induced nutritional deficiencies that increase heart failure risk.

Bottom line: The largest, most rigorous trial ever conducted shows beta-blockers provide no benefit for most heart attack survivors – and may harm women.  This challenges 40 years of practice and reminds us that optimal cardiovascular health comes from addressing root causes through nutrition, lifestyle, and strategic supplementation, not blindly following pharmaceutical protocols established decades ago.

Sources for this article include:

NEJM.org
Academic.oup.com
Sciencedaily.com

The post Common heart attack drug useless for most patients, major study reveals appeared first on NaturalHealth365.

Visit Natural Health 365 Here /

Source: https://www.naturalhealth365.com/common-heart-attack-drug-useless-for-most-patients-major-study-reveals.html